# Study of the Durability of Glycemic Control With Nateglinide

> **NCT00858013** · PHASE4 · COMPLETED · sponsor: **Ajou University School of Medicine** · enrollment: 88 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** Nateglinide
- **DRUG:** Glimepiride

## Key facts

- **NCT ID:** NCT00858013
- **Lead sponsor:** Ajou University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-04-24
- **Primary completion:** 2014-06-25
- **Final completion:** 2014-06-25
- **Target enrollment:** 88 (ACTUAL)
- **Last updated:** 2017-05-16

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00858013

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00858013, "Study of the Durability of Glycemic Control With Nateglinide". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00858013. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*